Duloxetine alleviates high light-induced anxiety-related behaviors in wistar rats

dc.contributor.authorÇalışkan, Hasan
dc.contributor.authorCihan, Koray Hamza
dc.contributor.authorGüneş, Emel
dc.contributor.authorErgün, Ahmet
dc.contributor.authorÖztürk, Mitat Can
dc.contributor.authorGençer, Şükrü Hakan
dc.contributor.authorKılınç, Süleyman
dc.contributor.authorOsmanov, Zakir
dc.contributor.authorKaya, Mehmet Oğuzhan
dc.contributor.authorKılıçdağı, Murat
dc.date.accessioned2020-01-16T08:42:12Z
dc.date.available2020-01-16T08:42:12Z
dc.date.issued2019en_US
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.descriptionÇalışkan, Hasan (Balikesir Author)en_US
dc.description.abstractPurpose: To investigate the effect of subchronic duloxetine treatment on high light-induced anxiety-related behaviors in Wistar rats. Methods: Adult male Wistar rats (n = 30) were randomly assigned to three groups of rats (10 rats/group): control group, 30 mg/kg duloxetine group, and 60 mg/kg duloxetine group. Intraperitoneal injection of duloxetine was given once a day for ten days. The anxiolytic effect of duloxetine in the rats was assessed using light/dark box (LDB) anxiety test. Results: Anxiety-related behaviors were significantly reduced in duloxetine-treated rats, when compared with control group. The reductions were not dose-dependent (light zone time and latency time were significantly increased, while dark zone time decreased significantly, p < 0.05). The number of rearings significantly increased in 30 mg/kg duloxetine group, relative to control and 60 mg/kg duloxetine groups (p < 0.05). However, there were no significant differences in the number of light-todark entrances among the groups (p > 0.05). Conclusion: These results show that subchronic treatment with duloxetine alleviates anxiety-related behaviors in Wistar rats.en_US
dc.identifier.doi10.4314/tjpr.v18i11.13
dc.identifier.endpage2323en_US
dc.identifier.issn1596-5996
dc.identifier.issue11en_US
dc.identifier.scopus2-s2.0-85078017374
dc.identifier.scopusqualityQ3
dc.identifier.startpage2319en_US
dc.identifier.urihttps://doi.org/10.4314/tjpr.v18i11.13
dc.identifier.urihttps://hdl.handle.net/20.500.12462/10488
dc.identifier.volume18en_US
dc.identifier.wosWOS:000500260000013
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherPharmacotherapy Groupen_US
dc.relation.ispartofTropical Journal of Pharmaceutical Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnxiety Disordersen_US
dc.subjectDuloxetineen_US
dc.subjectLight/Dark Box Testen_US
dc.subjectSubchronic Treatmenten_US
dc.subjectBehavioren_US
dc.titleDuloxetine alleviates high light-induced anxiety-related behaviors in wistar ratsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Duloxetinealleviateshighlight-inducedanxiety-related.pdf
Boyut:
408.05 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: